Uncovering the roots of Parkinson's disease, together
A global basic research initiative
Aligning Science Across Parkinson’s (ASAP) is fostering collaboration and resources to better understand the underlying causes of Parkinson’s disease. With scale, transparency, and open access data sharing, we believe we can accelerate the pace of discovery, and inform the path to a cure.
GP2 Launches Monogenic Hub
Through GP2’s Monogenic Hub, clinicians and researchers from around the world have the opportunity to submit data, access statistics, and learn more about ways to contribute to the investigation of people with Parkinson’s who potentially have a monogenic cause. The Monogenic Hub is also used to collect the results of genetics studies as well as anonymized global and aggregated data from other GP2 participating centers.
Meet ASAP’s 2020 Grantees
Meet the new members of ASAP’s Collaborative Research Network. Multidisciplinary investigators in 21 teams from 60 institutions across 11 countries, seek to accelerate targeted basic research and move us toward more meaningful advancements for Parkinson’s Disease. Get to know these talented scientists, their projects and how their outcomes will contribute to the field of PD.
GP2 Launches Training Platform
GP2’s new online learning platform makes development opportunities accessible and enables learners from around the world to explore courses on topics related to Parkinson’s disease genetics and a range of related areas. It is easy to register and available to everyone interested.
This article, authored by Drs. Ekemini A. U. Riley and Randy Schekman, delves into the ASAP initiative, highlighting its emphasis on open science and collaboration to improve understanding of the biology underlying the onset and progression of Parkinson’s Disease.